1Globe Capital LLC - Aug 13, 2025 SCHEDULE 13G Report for Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share

Filing Manager: 1Globe Capital LLC
Reporting Manager: 1Globe Capital LLC
Security: Crescent Biopharma, Inc. Ordinary Shares, par value $0.001 per share
Shares outstanding: 13.9M shares
Disclosed Ownership: 897K shares
Ownership: 6.45%
Form type: SCHEDULE 13G
Date filed: 8/20/2025, 05:20 PM
Date of event: Aug 13, 2025
Next filing: Oct 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
1Globe Capital LLC	6.45%	897K	0	897K	/s/ Jiaqiang Li	Chairman
Jiaqiang Li	6.45%	897K	0	897K	/s/ Jiaqiang Li	Reporting person